Related Experiment Video
Updated: Aug 15, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Aggressive Risk Factor Management in the Elderly: Are You Ever Too Old?
1Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO.
Insights
Smoking cessation and hypertension management are crucial for reducing cardiovascular disease risk in older adults. Treating high cholesterol also benefits older individuals, though treatment for those over 80 requires individual consideration.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Cardiovascular disease (CVD) is a major health concern in older adults.
- Smoking, hypertension, and hyperlipidemia are key modifiable risk factors for CVD.
Purpose of the Study:
- To review the impact of smoking, hypertension, and hyperlipidemia on cardiovascular disease in the elderly.
- To provide recommendations for managing these risk factors in older populations.
Main Methods:
- Literature review of clinical trials and epidemiological data.
- Analysis of risk factor prevalence and impact across different age groups.
Main Results:
- Smoking cessation rapidly reduces CVD risk in the elderly.
- Blood pressure reduction effectively lowers CVD risk, even in individuals up to 90 years old.
- Cholesterol reduction improves outcomes in those over 75, but treatment for those over 80 needs individualization.
Conclusions:
- Aggressive smoking cessation promotion is recommended for all ages.
- Treatment of both systolic and diastolic hypertension is strongly advised regardless of age.
- Hyperlipidemia management in the very elderly (over 80) requires personalized therapeutic strategies.
Abstract:
Smoking, hypertension, and hyperlipidemia are the three most important modifiable risk factors contributing to the development of cardiovascular disease in older adults. Although the magnitude of risk associated with smoking and hyperlipidemia declines with age, the absolute number of cases attributable to these risk factors increases due to the increasing prevalence of cardiovascular disease. Smoking increases the risk of both coronary events and stroke in the elderly, and there is evidence that smoking cessation is associated with a rapid reduction in risk. Therefore, an aggressive effort to promote smoking cessation is strongly recommended in patients of all ages. Systolic and diastolic hypertension are powerful risk factors for cardiovascular disease in the elderly. Moreover, multiple clinical trials have demonstrated that blood pressure reduction reduces the risk of stroke, coronary events, heart failure, and cardiovascular death in individuals at least up to the age of 90. Accordingly, treatment of both systolic and diastolic hypertension are strongly recommended regardless of patient age. The importance of total serum cholesterol as a coronary risk factor declines with age, but the ratio of low density lipoprotein cholesterol (LDL-C) to high density lipoprotein cholesterol (HDL-C) remains an independent predictor of coronary events in older men and women. In addition, clinical trials have shown that cholesterol reduction is associated with improved clinical outcomes in individuals at or above 75 years of age. At the present time, the value of treating hyperlipidemia in patients greater than 80 years of age is unknown, and therapy in this age group must be individualized. (c)1999 by CVRR, Inc.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Toxicity: Risk factors

